HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 80 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,000 | -76.2% | 426 | -62.0% | 0.00% | -20.0% |
| Q1 2022 | $21,000 | -43.2% | 1,121 | +6.7% | 0.01% | -37.5% |
| Q4 2021 | $37,000 | 0.0% | 1,051 | +3.3% | 0.01% | 0.0% |
| Q3 2021 | $37,000 | +8.8% | 1,017 | +19.1% | 0.01% | 0.0% |
| Q2 2021 | $34,000 | +61.9% | 854 | +15.7% | 0.01% | +60.0% |
| Q1 2021 | $21,000 | -12.5% | 738 | -1.3% | 0.01% | +25.0% |
| Q4 2020 | $24,000 | 0.0% | 748 | -0.7% | 0.00% | -20.0% |
| Q3 2020 | $24,000 | +26.3% | 753 | +7.4% | 0.01% | +25.0% |
| Q2 2020 | $19,000 | +46.2% | 701 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $13,000 | 0.0% | 701 | +30.3% | 0.00% | 0.0% |
| Q4 2019 | $13,000 | 0.0% | 538 | -22.9% | 0.00% | +50.0% |
| Q3 2019 | $13,000 | -40.9% | 698 | -2.5% | 0.00% | -50.0% |
| Q1 2019 | $22,000 | +37.5% | 716 | +5.1% | 0.00% | +33.3% |
| Q4 2018 | $16,000 | – | 681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Karst Peak Capital Ltd | 1,349,185 | $43,430,000 | 78.86% |
| AIA Investment Management Private Ltd | 354,035 | $11,396,000 | 2.43% |
| Bellevue Group AG | 400,029 | $12,877,000 | 0.82% |
| Prince Street Capital Management LLC | 81,400 | $2,620,000 | 0.55% |
| PRUDENTIAL PLC | 4,247,748 | $136,735,000 | 0.44% |
| OppenheimerFunds, Inc. | 2,936,797 | $94,536,000 | 0.11% |
| SECTORAL ASSET MANAGEMENT INC | 31,628 | $1,018,000 | 0.11% |
| Tibra Equities Europe Ltd | 27,900 | $898,000 | 0.11% |
| Jabre Capital Partners S.A. | 10,000 | $322,000 | 0.11% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 1,803,955 | $58,069,000 | 0.10% |